1. Home
  2. ROL vs ILMN Comparison

ROL vs ILMN Comparison

Compare ROL & ILMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rollins Inc.

ROL

Rollins Inc.

N/A

Current Price

$60.18

Market Cap

28.6B

Sector

Finance

ML Signal

N/A

Logo Illumina Inc.

ILMN

Illumina Inc.

N/A

Current Price

$129.59

Market Cap

18.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ROL
ILMN
Founded
1948
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Diversified Commercial Services
Medical Specialities
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
28.6B
18.9B
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
ROL
ILMN
Price
$60.18
$129.59
Analyst Decision
Buy
Hold
Analyst Count
10
15
Target Price
$66.20
$117.27
AVG Volume (30 Days)
2.4M
1.7M
Earning Date
10-29-2025
02-05-2026
Dividend Yield
1.23%
N/A
EPS Growth
9.81
N/A
EPS
1.06
4.46
Revenue
$3,680,306,000.00
$4,288,000,000.00
Revenue This Year
$12.58
N/A
Revenue Next Year
$9.23
$2.08
P/E Ratio
$55.84
$29.49
Revenue Growth
11.17
N/A
52 Week Low
$45.34
$68.70
52 Week High
$61.84
$153.06

Technical Indicators

Market Signals
Indicator
ROL
ILMN
Relative Strength Index (RSI) 53.51 56.87
Support Level $59.26 $126.44
Resistance Level $60.67 $137.09
Average True Range (ATR) 1.11 3.66
MACD -0.17 -0.62
Stochastic Oscillator 60.98 42.96

Price Performance

Historical Comparison
ROL
ILMN

About ROL Rollins Inc.

Rollins is a global leader in route-based pest control services, with operations primarily in the United States, as well as in North, Central, and South America, Europe, the Middle East, Africa, and Australia. Its portfolio of pest-control brands includes the prominent Orkin brand, a market leader in the US, which boasts near national coverage, and in Canada. They also have a litany of other brands, which they use to pursue customers via alternative sales channels. Residential pest and termite prevention dominates the services provided by Rollins, owing to the group's ongoing focus on the US and Canadian markets.

About ILMN Illumina Inc.

Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2024 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.

Share on Social Networks: